Obesity and Metabolic Associated Fatty Liver Disease (MAFLD) as Risk Factors for COVID-19 Severity

Author Info

Gamal Shiha Reham Soliman

Corresponding Author

Gamal Shiha
Egyptian Liver Research Institute and Hospital (ELRIAH), Sherbin, El Mansoura, Egypt

A B S T R A C T

In December 2019 Coronavirus disease 2019 (COVID-19) emerged in Wuhan, China and rapidly spread to other areas and has been declared a pandemic in 2020. Until now there are about half million deaths. Of note the highest fatality rate was found for cardiovascular disease, diabetes mellitus followed by chronic respiratory diseases, hypertension and cancer. Remarkably early data have reported higher BMI is associated with a higher risk of developing severe symptoms and complications of COVID-19 disease. Patients with metabolic associated fatty liver disease (MAFLD) are often obese and have additional metabolic risk factors which may increase risk of respiratory diseases. Identification of risk factors of COVID-19 severity is crucial to provide additional medical care; in this review we shed light on the association between MAFLD and COVID-19 severity.

Article Info

Article Type

Review Article

Publication history

Received: Wed 12, Aug 2020
Accepted: Fri 21, Aug 2020
Published: Fri 28, Aug 2020

Copyright

© 2023 Gamal Shiha. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.JDMC.2020.02.01